ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 82 filers reported holding ELEVATION ONCOLOGY INC in Q2 2024. The put-call ratio across all filers is 3.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $51,694 | +4012.5% | 19,146 | +7714.7% | 0.00% | – |
Q1 2024 | $1,257 | +874.4% | 245 | +1.7% | 0.00% | – |
Q4 2023 | $129 | -15.1% | 241 | +5.2% | 0.00% | – |
Q3 2023 | $152 | +2.0% | 229 | +133.7% | 0.00% | – |
Q2 2023 | $149 | -14.9% | 98 | +6.5% | 0.00% | – |
Q1 2023 | $175 | +103.5% | 92 | +2.2% | 0.00% | – |
Q4 2022 | $86 | – | 90 | +2.3% | 0.00% | – |
Q3 2022 | $0 | – | 88 | +109.5% | 0.00% | – |
Q2 2022 | $0 | – | 42 | +7.7% | 0.00% | – |
Q1 2022 | $0 | – | 39 | +2.6% | 0.00% | – |
Q4 2021 | $0 | – | 38 | 0.0% | 0.00% | – |
Q3 2021 | $0 | – | 38 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Qiming U.S. Ventures Management, LLC | 2,370,142 | $1,570,456 | 2.08% |
Aisling Capital Management LP | 2,834,910 | $1,878,411 | 0.77% |
venBio Partners LLC | 2,914,255 | $1,930,985 | 0.55% |
TANG CAPITAL MANAGEMENT LLC | 4,000,000 | $2,650,400 | 0.37% |
Velan Capital Investment Management LP | 497,299 | $329,510 | 0.27% |
SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $596,340 | 0.11% |
DAFNA Capital Management LLC | 450,000 | $298,170 | 0.09% |
Ikarian Capital, LLC | 1,171,939 | $776,527 | 0.09% |
CAXTON CORP | 21,813 | $14,453 | 0.06% |
BVF INC/IL | 2,312,200 | $1,532,064 | 0.04% |